Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus

Objective. Systemic lupus erythematosus (SLE) is treated with anti-inflammatory and immunosuppressive drugs and off-label biologics. Belimumab is the first biologic approved after 50 years as an add-on therapy for active disease. This paper summarizes a health technology assessment performed in Ital...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Specchia, Maria Lucia, de Waure, Chiara, Gualano, Maria Rosaria, Doria, Andrea, Turchetti, Giuseppe, Pippo, Lara, Di Nardo, Francesco, Capizzi, Silvio, Cadeddu, Chiara, Kheiraoui, Flavia, Iaccarino, Luca, Pierotti, Francesca, Palla, Ilaria, Veneziano, Maria Assunta, Gliubizzi, Daniela, Sferrazza, Antonella, Nicolotti, Nicola, Porcasi, Rolando, La Torre, Giuseppe, Di Pietro, Maria Luisa, Ricciardi, Walter
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150460/
https://ncbi.nlm.nih.gov/pubmed/25243173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/704207
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky